Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Published 06/06/2023, 18:04
Updated 06/06/2023, 21:10
© Reuters.  Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga - Gainers

  • Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq.
  • Hoth Therapeutics, Inc. (NASDAQ: HOTH) rose 96% to $3.6850 after the company announced preclinical results for HT-ALZ for the treatment of Alzheimer's disease.
  • Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) shares rose 37.8% to $0.5928.
  • Zura Bio Limited (NASDAQ: ZURA) shares gained 25% to $8.11 after the company completed approximately $80 million financing with the focus on advancing ZB-106, a potential first-in-class anti-IL-17 and anti-BAFF dual antagonist.
  • Xunlei Limited (NASDAQ: XNET) rose 22% to $1.6715. Xunlei launched a $20 million share buyback program.
  • G-III Apparel Group, Ltd. (NASDAQ: GIII) gained 21.7% to $20.13 following first-quarter results. G-III Apparel reported a master licensing partnership with Xcel Brands to design and produce all categories and distribute products globally for the Halston business and all of its brands.
  • GT Biopharma, Inc. (NASDAQ: GTBP) rose 20.7% to $0.35.
  • Secoo Holding Limited (NASDAQ: SECO) gained 20.2% to $0.9739.
  • GitLab Inc. (NASDAQ: GTLB) shares climbed 19.9% to $42.43 after the company reported better-than-expected first-quarter results. Multiple analysts raised their price targets on the stock following the report.
  • Big Lots, Inc. (NYSE: BIG) gained 18.1% to $6.97.
  • Chijet Motor Company, Inc. (NASDAQ: TTOO) shares surged 18.1% to $0.0827after dipping around 31% on Monday. T2 Biosystems reported submission for the FDA breakthrough device designation for candida auris diagnostic test.
  • Castle Biosciences, Inc. (NASDAQ: CSTL) gained 18.8% to $13.86. Canaccord Genuity maintained Castle Biosciences with a Buy and lowered the price target from $60 to $40.
  • Novo Integrated Sciences, Inc. (NASDAQ: NVOS) rose 17% to $0.1478. Novo Integrated Sciences recently posted a first-quarter loss of 12 cents per share.
  • AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) gained 16.4% to $0.2213.
  • MicroVision, Inc. (NASDAQ: MVIS) gained 15.3% to $6.14.
  • PARTS iD, Inc. (NYSE: ID) climbed 15.3% to $0.4070.
  • AlloVir, Inc. (NASDAQ: ALVR) gained 15.3% to $5.15.
  • THOR Industries, Inc. (NYSE: THO) rose 14.6% to $90.69 after the company reported better-than-expected third-quarter results and raised its FY23 EPS guidance.
  • Synlogic, Inc. (NASDAQ: SYBX) gained 14.3% to $0.5601. HC Wainwright & Co. reiterated Synlogic with a Buy and maintained a $5 price target.
  • Outlook Therapeutics, Inc. (NASDAQ: OTLK) gained 11.7% to $1.9550.
  • HealthEquity, Inc. (NASDAQ: HQY) rose 11.3% to $65.51 following strong quarterly results.
  • Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) climbed 9.2% to $17.25.
  • FiscalNote Holdings, Inc. (NYSE: NOTE) gained 9% to $2.55.
  • Stem, Inc. (NASDAQ: STEM) gained 7.7% to $6.00. Janney Montgomery Scott initiated coverage on Stem with a Buy rating and announced a price target of $12.
  • Sprinklr, Inc. (NYSE: CXM) climbed 7.5% to $14.52 after the company reported better-than-expected earnings and sales results for its first quarter.
  • Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares climbed 7.3% to $2.7250. Lexicon Pharmaceuticals 10% owner Invus Advisors LLC acquired a total 27,775,050 shares an average price of $2.60.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • Tingo Group, Inc. (NASDAQ: TIO) shares fell 52.8% to $1.2050. A short report from Hindenburg Research has hit Tingo Group, calling it an "exceptionally obvious scam" with alleged falsified financials.
  • HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) fell 40.3% to $1.00 after dropping over 20% on Monday.
  • JOANN Inc. (NASDAQ: JOAN) fell 28.7% to $1.1473 following weak quarterly results.
  • NovoCure Limited (NASDAQ: NVCR) fell 28.5% to $59.02. NovaCure disclosed results from the Phase 3 LUNAR clinical trial evaluating the use of tumor treating fields therapy with standard treatment therapies and said it met its primary endpoint at 2023 ASCO Annual Meeting.
  • Wejo Group Limited (NASDAQ: WEJO) shares declined 25.6% to $0.0632.
  • Ucommune International Ltd (NASDAQ: UK) shares dropped 23.5% to $0.7693 after surging over 50% on Monday.
  • Chijet Motor Company, Inc. (NASDAQ: CJET) fell 21.3% to $4.6408.
  • Sono Group N.V. (NASDAQ: SEV) fell 20.3% to $0.2432 after gaining around 76% on Monday.
  • Better Choice Company Inc. (NYSE: BTTR) fell 19.1% to $0.2039.
  • MultiMetaVerse Holdings Limited (NASDAQ: MMV) dropped 18.2% to $1.80.
  • Nevro Corp. (NYSE: NVRO) dropped 17% to $22.85. Several analysts cut their price targets on the stock.
  • Appreciate Holdings, Inc. (NASDAQ: SFR) fell 15.5% to $0.2463.
  • Coinbase Global, Inc. (NASDAQ: COIN) fell 14.3% to $50.41 after the SEC sued the company in NY federal court.
  • Leap Therapeutics, Inc. (NASDAQ: LPTX) declined 14.4% to $0.7248.
  • Wearable Devices Ltd. (NASDAQ: WLDS) fell 14% to $1.84.
  • WeWork Inc. (NYSE: WE) fell 12.1% to $0.2015.
  • Bausch Health Companies Inc. (NYSE: BHC) dropped 11.9% to $6.99.
  • Ciena Corporation (NYSE: CIEN) fell 11.5% to $42.06 following second-quarter results.
  • Bluejay Diagnostics, Inc. (NASDAQ: BJDX) fell 10% to $0.2050. Bluejay Diagnostics filed for mixed shelf of up to $25 million.
  • Blue Bird Corporation (NASDAQ: BLBD) dipped 8.4% to $23.03. Blue Bird announced a secondary public offering of 5 million shares.
  • Pasithea Therapeutics Corp (NASDAQ: KTTA) shares dropped 7.6% to $0.4622. Pasithea Therapeutics shares jumped 25% on Monday after Lucy Scientific Discovery proposed to acquire the company for $0.60 per share in cash and $0.25 per share in Lucy stock.
  • View, Inc. (NASDAQ: VIEW) fell 6.7% to $0.1817. View announced plans for reverse stock split to ensure full compliance with Nasdaq listing rules.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: Ethereum Drops But Remains Above $1,800; Sandbox, Pepe Among Top Losers

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.